Azerbaijan National Academy of Sciences

Production of a European vaccine against the coronavirus will begin in September, said Piero Di Lorenzo, head of the Italian biotech company Irbm.

British and Italian specialists are working on a drug called ChAdOx1, in particular the multinational pharmaceutical group AstraZeneca, Oxford University scientists and Irbm specialists working in the field of molecular biotechnology.

"The ChAdOx1 vaccine has already been successfully tested on 1,000 patients. We are now in the third phase of work, testing on 10,000 people. If all goes well, it is reasonable to assume that large volumes of production could begin in late September," Dee said. Lorenzo in an interview with the Libero newspaper.

ria.ru